Novartis Q1 profit up 49 per cent
Drug maker Novartis says its first-quarter net profit has increased 49 per cent to $2.95 billion (SFr3.14 billion) on strong sales, particularly of swine flu vaccine.
The Swiss pharmaceutical giant reported a net profit of $1.98 billion in the same quarter a year ago.
Sales rose 25 per cent to $12.13 billion in the January-March period from $9.71 billion the previous year.
The results reported on Tuesday beat analysts’ expectations for a net profit of some $2.49 billion.
swissinfo.ch and agencies
More
Will Switzerland finally do away with imputed rental-value tax on homeowners?
More
Can democracy still make a place richer?
More
When a US bomber crashed into Max Huber’s Zurich castle
More
A Geneva-based global health foundation came close to ‘collapse’. Where were regulators?
More
Velcro: how space race helped Swiss invention catch on
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.